Literature DB >> 2254774

An inconsistent relationship between insulin and blood pressure in three Pacific island populations.

V R Collins1, G K Dowse, C F Finch, P Z Zimmet.   

Abstract

The evidence linking insulin to blood pressure is controversial, and results for groups similarly categorized by body mass, glucose tolerance and hypertensive status are often contradictory. We have investigated the relationship in three population-based samples of Micronesian (Nauru), Polynesian (Western Samoa) and Melanesian (New Caledonia) Pacific islanders, who are known to be susceptible to obesity, non-insulin-dependent diabetes mellitus (NIDDM), hyperinsulinaemia and hypertension. After controlling for age and body mass index (BMI), mean fasting and 2-hr (post 75 g glucose) insulin levels were not significantly different between hypertensive and non-hypertensive subjects, in any population or glucose tolerance sub-group, excepting 2-hr insulin in New Caledonians with normal glucose tolerance. Similarly, there were no strong trends for a higher prevalence of hypertension amongst those with insulin levels in the upper quartile of the distribution of each population, although it was apparent in some BMI/glucose tolerance sub-groups of two populations. Multiple linear regression analyses also showed an inconsistent and where present, weak, independent association between insulin and blood pressure in models predicting both systolic and diastolic blood pressure. We therefore conclude that the hypothesis implicating insulin as a major determinant of blood pressure and as the pathophysiological link between obesity, NIDDM and hypertension is not strongly supported either by the literature or the present data.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2254774     DOI: 10.1016/0895-4356(90)90104-w

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  7 in total

Review 1.  The metabolic syndrome and related cardiovascular risk.

Authors:  F Ramos; H P Baglivo; A J Ramírez; R Sánchez
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

2.  Does impaired glucose tolerance predict hypertension? A prospective analysis.

Authors:  O Vaccaro; G Imperatore; V Iovino; C Iovine; A A Rivellese; G Riccardi
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

Review 3.  Clinical efficacy of metformin against insulin resistance parameters: sinking the iceberg.

Authors:  P Zimmet; G Collier
Journal:  Drugs       Date:  1999       Impact factor: 9.546

4.  Insulin and atherosclerosis: villain, accomplice, or innocent bystander?

Authors:  P J Savage; M F Saad
Journal:  Br Heart J       Date:  1993-06

Review 5.  Role of hypertension in the metabolic syndrome: who is affected?

Authors:  Gladys Velarde; Bradford C Berk
Journal:  Curr Hypertens Rep       Date:  2005-12       Impact factor: 5.369

6.  Hypertension and overweight associated with hyperinsulinaemia and glucose tolerance: a longitudinal study of the Finnish and Dutch cohorts of the Seven Countries Study.

Authors:  E J Feskens; J Tuomilehto; J H Stengård; J Pekkanen; A Nissinen; D Kromhout
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

7.  High inflammatory activity related to the number of metabolic syndrome components.

Authors:  Bahadir Kirilmaz; Fatih Asgun; Emin Alioglu; Ertugrul Ercan; Istemihan Tengiz; Ugur Turk; Serkan Saygi; Filiz Ozerkan
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-02-01       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.